Last updated: May 26, 2026
Who supplies chlorhexidine gluconate for pharmaceutical use?
Chlorhexidine gluconate is supplied into pharma supply chains primarily as either (1) the active ingredient solution (API in aqueous gluconate form) or (2) as higher-purity intermediates used to formulate antiseptic and wound-care products.
Common supply tiers
- API solution suppliers: Sell chlorhexidine gluconate solution (often 20% strength) or pharma-grade aqueous solutions under GMP.
- Contract manufacturers (finishing/packaging): Convert API solution into finished bulk containers (drums/IBC) or sub-bulk.
- Excipients/system inputs: Specialty grades (low endotoxin, controlled impurities, controlled microbial limits) depending on intended use.
Major global supplier groups used in pharma chains
The supplier set typically includes large chemical manufacturers plus dedicated pharma ingredients firms. In practice, sourcing is concentrated among a limited number of companies capable of producing:
- controlled impurities for USP/EP specs,
- appropriate microbial and endotoxin control,
- consistent viscosity and concentration targets for formulation.
(No complete supplier list can be produced from the information provided.)
Who supplies isopropyl alcohol (IPA) for pharmaceutical use?
Pharmaceutical use of isopropyl alcohol focuses on supply for:
- disinfection and antiseptic formulations,
- manufacturing solvent needs (cleaning, wetting, solvent for excipient manufacturing depending on the site),
- process use in sterile and non-sterile production (under site-specific GMP controls).
What “pharma-grade IPA” usually means
IPA suppliers for pharma typically provide:
- consistent assay and water content,
- low nonvolatile residue where required,
- suitable denaturant status (if applicable),
- GMP documentation and CoA traceability for regulated manufacturing.
Typical supplier categories
- Major chemical producers: Large-volume IPA supply with regulated quality systems.
- Specialty alcohol producers: Focus on tighter specs and controlled impurities.
- Distributors with GMP sourcing: Repackage or supply bulk IPA from qualified producers for pharma customers.
(No complete supplier list can be produced from the information provided.)
Which suppliers provide chlorhexidine gluconate and isopropyl alcohol as regulated GMP inputs?
Procurement teams usually qualify suppliers by:
- GMP capability for drug substance or controlled substances inputs,
- ability to provide batch-level CoAs, impurities profiles, and change control,
- ability to support audits, DMFs where applicable, and regulatory documentation for intended use.
Supplier qualification checkpoints
- Documented control of nitrosamines and genotoxic impurities is not typically relevant to these two inputs the way it is for small-molecule APIs, but impurity profiling and spec control are still key.
- Microbial limits and endotoxin controls matter for antiseptic liquid inputs and some formulation settings.
- Consistency of concentration is essential for chlorhexidine gluconate solution and for IPA strength targets.
(No complete supplier list can be produced from the information provided.)
What delivery formats do suppliers use for chlorhexidine gluconate?
Chlorhexidine gluconate is typically supplied as:
- aqueous solution bulk (commonly 20% strength, depending on downstream formulation needs),
- bulk containers (drums/IBCs) for pharma formulation sites.
Downstream formulation sensitivity
- Chlorhexidine gluconate viscosity and stability depend on concentration and temperature history.
- Compatibility with formulation excipients drives procurement of consistent-grade solutions.
(No complete supplier list can be produced from the information provided.)
What delivery formats do suppliers use for pharmaceutical isopropyl alcohol?
IPA is supplied as:
- bulk liquid in drums/ISO tanks/IBC,
- specified grades depending on water content and impurity profile requirements.
Common pharma sourcing controls
- Sterility is not typically demanded for IPA itself, but impurity limits and microbial acceptance criteria can apply depending on process stage.
- Traceability and packaging integrity are required for GMP use.
(No complete supplier list can be produced from the information provided.)
What are the key sourcing constraints for these inputs?
Chlorhexidine gluconate
- Tight impurity specs and consistent concentration across lots.
- Microbial and endotoxin control depending on finished product target patient population and intended application.
Isopropyl alcohol
- Water content and nonvolatile residue control tied to formulation and process reproducibility.
- Documentation required for regulated manufacturing sites, including CoA and change control.
(No complete supplier list can be produced from the information provided.)
How does supplier availability affect supply risk for chlorhexidine gluconate and IPA?
Supply risk typically comes from:
- concentration or spec changes that trigger requalification by formulation sites,
- logistics disruptions for bulk liquids,
- regional regulatory or transport constraints for flammable IPA.
(No complete supplier list can be produced from the information provided.)
Key Takeaways
- Chlorhexidine gluconate is sourced mainly as aqueous GMP-grade solution for antiseptic and wound-care formulations, with supplier qualification focused on impurity profiles, concentration consistency, and microbial/endotoxin controls.
- Isopropyl alcohol is sourced as bulk pharma-grade IPA with supplier qualification focused on assay, water/nonvolatile residue, impurity controls, and GMP documentation for regulated manufacturing.
- A complete, named supplier list cannot be generated from the information provided.
FAQs
- What grade of chlorhexidine gluconate is typically purchased for pharmaceutical antiseptic formulations?
- What impurity or spec items are most critical for qualifying isopropyl alcohol for GMP manufacturing use?
- Do chlorhexidine gluconate suppliers provide 20% solution only, or multiple strengths for pharma procurement?
- How do pharmaceutical manufacturers verify lot-to-lot consistency for bulk chlorhexidine gluconate solution?
- What documentation is required from IPA suppliers for audits at sterile and non-sterile manufacturing sites?
References (APA)
- No sources cited.
